Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

Volume VIII No. #15 - November 5, 2001

The Reality of Wide Scale Biological Attacks

Commentary and Opinion by R. Lewis Dark /

MY TOPIC TODAY CONCERNS THE POTENTIAL FOR A BIOTERRORIST ATTACK to infect Americans on a vast scale. As most know, health authorities are struggling to explain new cases of pulmonary and cutaneous anthrax in victims with no obvious connections to contaminated mail or the post office. I consider this to be evidence that the infectious […]

To access this post, you must purchase The Dark Report.

The Reality of Wide Scale Biological Attacks Read More »

Labs in NY & Wash, DC Get Anthrax Test Orders

Clinical Laboratory /

CEO SUMMARY: In both New York City and Washington, DC, widespread publicity about exposure to anthrax generated a steady volume of test requests. Clinical labs in both cities adopted similar management strategies to deal with the sudden public interest in anthrax testing. One common step was to send detailed information about anthrax testing to physician

To access this post, you must purchase The Dark Report.

Labs in NY & Wash, DC Get Anthrax Test Orders Read More »

New Legal Trends Now Affecting Pathologists

Pathology Trends /

CEO SUMMARY: During the past 36 months, quiet and significant changes have occurred to certain legal issues involving anatomic pathology services. The resulting new environment exposes pathology groups to different types of threats, particularly to their sources of income. This intelligence briefing launches a new series concerning the law and pathology. WITHOUT MUCH ATTENTION or

To access this post, you must purchase The Dark Report.

New Legal Trends Now Affecting Pathologists Read More »

Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging

Clinical Laboratory /

ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has instrument systems well-suited for both testing categories. Its DNA analyzers will compete with systems from Applied Biosystems and

To access this post, you must purchase The Dark Report.

Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging Read More »

Pricing Models and RFP Terms For Web Orders and Results

Laboratory Information Systems /

CEO SUMMARY: Browser-based systems for lab test ordering and results reporting are now offered by a growing number of vendors. Early adopter labs are successfully acquiring these systems and offering them to their physician-clients. In this third installment of our special series, Cory Fishkin explains how to develop effective RFPs (Request For Proposals). He also

To access this post, you must purchase The Dark Report.

Pricing Models and RFP Terms For Web Orders and Results Read More »

Certain Medicare Lab Reforms May Make It Through Congress

Clinical Laboratory Trends /

ONE CONSEQUENCE of the terrorist attacks on September 11 is that proposed reforms to Medicare lab reimbursement policies have assumed a lesser priority with the current Congress. Despite that fact, Congress must still address the day-to-day requirements of managing government functions. Thus, there is still activity under way to develop and pass bills affecting funding

To access this post, you must purchase The Dark Report.

Certain Medicare Lab Reforms May Make It Through Congress Read More »

Quest Buys New Jersey Lab, Lab Investors Cash In Stock

Clinical Laboratory Trends /

THERE’S LOTS OF BUYING and selling taking place among the public laboratory companies. On one side of the spectrum, Quest Diagnostics Incorporated announced the acquisition of Clinical Diagnostic Services, Inc., a private laboratory company based in Englewood, New Jersey. Clinical Diagnostic Services (CDS) was one of the largest independent lab companies remaining in the United States,

To access this post, you must purchase The Dark Report.

Quest Buys New Jersey Lab, Lab Investors Cash In Stock Read More »

“November 5, 2001 Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

It’s a milestone in the Pap smear testing marketplace. Cytyc Corporation, in its third quarter financial report, now claims its Thin-Prep® product has 51% of the national market for Pap testing. Estimates are that 55 million Pap tests are done annually in the United States. A 51% market share translates into 28 million ThinPrep tests

To access this post, you must purchase The Dark Report.

“November 5, 2001 Intelligence: Late Breaking Lab News” Read More »

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved.

;